Bioteque Corporation (TPEX:4107)

Market Cap	7.21B -14.4%
Revenue (ttm)	2.22B +5.4%
Net Income	589.44M +12.3%
EPS	8.46 +12.2%
Shares Out	69.30M
PE Ratio	12.30
Forward PE	n/a
Dividend	5.50 (5.29%)
Ex-Dividend Date	Jul 28, 2026

Volume	224,223
Open	103.00
Previous Close	104.00
Day's Range	100.50 - 104.00
52-Week Range	102.00 - 132.00
Beta	0.16
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 11, 2026

About Bioteque

Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company offers angiography catheter, balloon dilation catheter, guiding sheath, guide steel wire, y-type connector, multi-pipe joint, connecting pipe, y-type connector assembly, peripheral vascular guiding catheter, coronary balloon dilation catheter, central venous catheter, microcatheter assembly, injection tube sleeve assembly for radiographic catheters, micro-puncture guide assembly, closed suction catheter, oxygen mas...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4107

Financial Performance

In 2025, Bioteque's revenue was 2.14 billion, an increase of 3.03% compared to the previous year's 2.07 billion. Earnings were 539.19 million, an increase of 2.07%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 6, 2026

Data Sources Report a data error